Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 25% ± 6% | |
pericyte | 3 studies | 25% ± 8% |
Insufficient scRNA-seq data for expression of GPER1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 969.95 | 2586 / 2642 | 99% | 14.89 | 701 / 705 |
thymus | 98% | 1272.60 | 642 / 653 | 92% | 15.99 | 555 / 605 |
kidney | 96% | 833.52 | 85 / 89 | 89% | 28.04 | 801 / 901 |
liver | 96% | 1535.53 | 218 / 226 | 88% | 17.67 | 356 / 406 |
prostate | 97% | 899.34 | 238 / 245 | 82% | 8.89 | 412 / 502 |
breast | 96% | 1029.09 | 441 / 459 | 50% | 8.66 | 556 / 1118 |
adrenal gland | 99% | 1513.18 | 255 / 258 | 44% | 8.75 | 101 / 230 |
uterus | 95% | 702.33 | 162 / 170 | 41% | 4.79 | 190 / 459 |
stomach | 100% | 3378.35 | 359 / 359 | 32% | 2.49 | 91 / 286 |
intestine | 95% | 942.38 | 917 / 966 | 30% | 3.04 | 160 / 527 |
esophagus | 80% | 692.13 | 1161 / 1445 | 42% | 3.25 | 77 / 183 |
skin | 64% | 239.21 | 1161 / 1809 | 53% | 5.54 | 248 / 472 |
bladder | 95% | 712.62 | 20 / 21 | 19% | 1.27 | 98 / 504 |
lung | 80% | 1494.37 | 464 / 578 | 31% | 2.25 | 359 / 1155 |
spleen | 99% | 1015.93 | 239 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 1250.59 | 1179 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 841.12 | 1270 / 1335 | 0% | 0 | 0 / 0 |
ovary | 62% | 241.61 | 112 / 180 | 27% | 1.80 | 116 / 430 |
eye | 0% | 0 | 0 / 0 | 89% | 14.71 | 71 / 80 |
heart | 82% | 354.72 | 703 / 861 | 0% | 0 | 0 / 0 |
pancreas | 20% | 54.02 | 65 / 328 | 62% | 4.40 | 110 / 178 |
peripheral blood | 62% | 717.96 | 576 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 6.24 | 15 / 29 |
tonsil | 0% | 0 | 0 / 0 | 47% | 5.76 | 21 / 45 |
muscle | 25% | 66.88 | 198 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002695 | Biological process | negative regulation of leukocyte activation |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0071389 | Biological process | cellular response to mineralocorticoid stimulus |
GO_0006954 | Biological process | inflammatory response |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0030264 | Biological process | nuclear fragmentation involved in apoptotic nuclear change |
GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0070474 | Biological process | positive regulation of uterine smooth muscle contraction |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_2000724 | Biological process | positive regulation of cardiac vascular smooth muscle cell differentiation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_2000353 | Biological process | positive regulation of endothelial cell apoptotic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0010948 | Biological process | negative regulation of cell cycle process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0045087 | Biological process | innate immune response |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0032962 | Biological process | positive regulation of inositol trisphosphate biosynthetic process |
GO_0019228 | Biological process | neuronal action potential |
GO_0071375 | Biological process | cellular response to peptide hormone stimulus |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0007399 | Biological process | nervous system development |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0042311 | Biological process | vasodilation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0051055 | Biological process | negative regulation of lipid biosynthetic process |
GO_0030518 | Biological process | nuclear receptor-mediated steroid hormone signaling pathway |
GO_1904706 | Biological process | negative regulation of vascular associated smooth muscle cell proliferation |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0030263 | Biological process | apoptotic chromosome condensation |
GO_0045745 | Biological process | positive regulation of G protein-coupled receptor signaling pathway |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0030154 | Biological process | cell differentiation |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0043679 | Cellular component | axon terminus |
GO_0098686 | Cellular component | hippocampal mossy fiber to CA3 synapse |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0032591 | Cellular component | dendritic spine membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0045095 | Cellular component | keratin filament |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0044327 | Cellular component | dendritic spine head |
GO_0005886 | Cellular component | plasma membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0043198 | Cellular component | dendritic shaft |
GO_0005769 | Cellular component | early endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0005829 | Cellular component | cytosol |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0030284 | Molecular function | nuclear estrogen receptor activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0005496 | Molecular function | steroid binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_1990239 | Molecular function | steroid hormone binding |
GO_0038054 | Molecular function | G protein-coupled estrogen receptor activity |
Gene name | GPER1 |
Protein name | G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER) G protein-coupled estrogen receptor 1 |
Synonyms | CEPR CMKRL2 DRY12 GPR30 GPER |
Description | FUNCTION: G-protein coupled estrogen receptor that binds to 17-beta-estradiol (E2) with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways. Stimulates cAMP production, calcium mobilization and tyrosine kinase Src inducing the release of heparin-bound epidermal growth factor (HB-EGF) and subsequent transactivation of the epidermal growth factor receptor (EGFR), activating downstream signaling pathways such as PI3K/Akt and ERK/MAPK. Mediates pleiotropic functions among others in the cardiovascular, endocrine, reproductive, immune and central nervous systems. Has a role in cardioprotection by reducing cardiac hypertrophy and perivascular fibrosis in a RAMP3-dependent manner. Regulates arterial blood pressure by stimulating vasodilation and reducing vascular smooth muscle and microvascular endothelial cell proliferation. Plays a role in blood glucose homeostasis contributing to the insulin secretion response by pancreatic beta cells. Triggers mitochondrial apoptosis during pachytene spermatocyte differentiation. Stimulates uterine epithelial cell proliferation. Enhances uterine contractility in response to oxytocin. Contributes to thymic atrophy by inducing apoptosis. Attenuates TNF-mediated endothelial expression of leukocyte adhesion molecules. Promotes neuritogenesis in developing hippocampal neurons. Plays a role in acute neuroprotection against NMDA-induced excitotoxic neuronal death. Increases firing activity and intracellular calcium oscillations in luteinizing hormone-releasing hormone (LHRH) neurons. Inhibits early osteoblast proliferation at growth plate during skeletal development. Inhibits mature adipocyte differentiation and lipid accumulation. Involved in the recruitment of beta-arrestin 2 ARRB2 at the plasma membrane in epithelial cells. Functions also as a receptor for aldosterone mediating rapid regulation of vascular contractibility through the PI3K/ERK signaling pathway. Involved in cancer progression regulation. Stimulates cancer-associated fibroblast (CAF) proliferation by a rapid genomic response through the EGFR/ERK transduction pathway. Associated with EGFR, may act as a transcription factor activating growth regulatory genes (c-fos, cyclin D1). Promotes integrin alpha-5/beta-1 and fibronectin (FN) matrix assembly in breast cancer cells. . |
Accessions | Q99527 ENST00000401670.1 ENST00000397088.4 C9J3W2 ENST00000397092.5 ENST00000297469.3 ENST00000413368.5 |